Kamada - High Quality Pharmaceuticals
High Quality Pharmaceuticals

Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique protein purification technology.
Kamada´s product line consists of more than 10 injectable pharmaceutical products which are marketed in more than 15 countries worldwide.

Read more

Watch the Inhaled AAT Phase II/III Panel Discussion which took place During the ATS

New Prospects for AAT patients – Presentation from the ATS conference

Updated data from the Company’s Phase 2/3 clinical study of inhaled Alpha-1 antitrypsin (AAT) to treat alpha-1 antitrypsin deficiency (AATD) presented during a panel discussion entitled, “New Treatment Prospects for AATD Patients: Results from a Phase 2/3 Inhaled AAT Trial.”  The panel, led by Key Opinion Leaders (KOLs) who specialize in treating patients with AATD, was held during the American Thoracic Society (ATS) 2015 International Conference held from May 15-20, 2015 in Denver, Colorado.

Link to full presentation

Kamada Highlights Video